Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schlaak

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Communications Medicine|September 10, 2024
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient careLukas Heinlein, Roman C Maron, Achim Hekler, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentGeorg C Lodde, Philipp Jansen, Inga Möller, et al.
The New England Journal of Medicine|October 23, 2023
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal MelanomaJessica C Hassel, Sophie Piperno-Neumann, Piotr Rutkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2021
Hematological immune related adverse events after treatment with immune checkpoint inhibitorsRafaela Kramer, Anne Zaremba, Alvaro Moreira, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2021
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classificationJulia Höhn, Eva Krieghoff-Henning, Tanja B Jutzi, et al.
JAMA Dermatology|February 7, 2024
Federated Learning for Decentralized Artificial Intelligence in Melanoma DiagnosticsSarah Haggenmüller, Max Schmitt, Eva Krieghoff-Henning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> MutationsChristian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2022
Explainable artificial intelligence in skin cancer recognition: A systematic reviewKatja Hauser, Alexander Kurz, Sarah Haggenmüller, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
Data in Brief|November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitisLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Communications Medicine|September 10, 2024
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient careLukas Heinlein, Roman C Maron, Achim Hekler, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentGeorg C Lodde, Philipp Jansen, Inga Möller, et al.
The New England Journal of Medicine|October 23, 2023
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal MelanomaJessica C Hassel, Sophie Piperno-Neumann, Piotr Rutkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2021
Hematological immune related adverse events after treatment with immune checkpoint inhibitorsRafaela Kramer, Anne Zaremba, Alvaro Moreira, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2021
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classificationJulia Höhn, Eva Krieghoff-Henning, Tanja B Jutzi, et al.
JAMA Dermatology|February 7, 2024
Federated Learning for Decentralized Artificial Intelligence in Melanoma DiagnosticsSarah Haggenmüller, Max Schmitt, Eva Krieghoff-Henning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> MutationsChristian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2022
Explainable artificial intelligence in skin cancer recognition: A systematic reviewKatja Hauser, Alexander Kurz, Sarah Haggenmüller, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
Data in Brief|November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitisLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
Pageof 10